TY - JOUR
T1 - [Usefulness of esophageal stenting for esophagorespiratory fistula with esophageal cancer].
AU - Konosu, Masafumi
AU - Kimura, Yusuke
AU - Iwaya, Takeshi
AU - Akiyama, Yuji
AU - Fujiwara, Hisataka
AU - Endo, Fumitaka
AU - Sugitachi, Akio
AU - Nishizuka, Satoshi
AU - Nitta, Hiroyuki
AU - Otsuka, Koki
AU - Kashiwaba, Masahiro
AU - Koeda, Keisuke
AU - Sasaki, Akira
AU - Mizuno, Masaru
AU - Wakabayashi, G.
PY - 2012/11
Y1 - 2012/11
N2 - We evaluated the outcome of esophageal stenting for esophagorespiratory fistula in patients with advanced esophageal cancer. Six patients with such fistula underwent esophageal stenting at our department from January 2000 to May 2012. Intraoral ingestion improved in all patients. Cough decreased immediately after stenting in 3 patients, and pneumonia detected by chest radiography improved within 1 week in 2 patients. Ventilation was weaned 2 days after stenting in 1 patient. The median survival duration after stenting was 31 days, and the cause of death was cancer in all patients. The following background factors were identified at the time of death: bleeding(n=3), mediastinitis(n=1), and pneumonia(n=1). Esophageal stenting, which should always be performed with the informed consent of the patient, improves respiratory symptoms, intraoral ingestion, and quality of life. Therefore, it is one of the best palliative therapies for patients with esophagorespiratory fistula associated with advanced esophageal cancer.
AB - We evaluated the outcome of esophageal stenting for esophagorespiratory fistula in patients with advanced esophageal cancer. Six patients with such fistula underwent esophageal stenting at our department from January 2000 to May 2012. Intraoral ingestion improved in all patients. Cough decreased immediately after stenting in 3 patients, and pneumonia detected by chest radiography improved within 1 week in 2 patients. Ventilation was weaned 2 days after stenting in 1 patient. The median survival duration after stenting was 31 days, and the cause of death was cancer in all patients. The following background factors were identified at the time of death: bleeding(n=3), mediastinitis(n=1), and pneumonia(n=1). Esophageal stenting, which should always be performed with the informed consent of the patient, improves respiratory symptoms, intraoral ingestion, and quality of life. Therefore, it is one of the best palliative therapies for patients with esophagorespiratory fistula associated with advanced esophageal cancer.
UR - http://www.scopus.com/inward/record.url?scp=84875903855&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875903855&partnerID=8YFLogxK
M3 - Article
C2 - 23267907
AN - SCOPUS:84875903855
SN - 0385-0684
VL - 39
SP - 1849
EP - 1851
JO - Gan to kagaku ryoho. Cancer & chemotherapy
JF - Gan to kagaku ryoho. Cancer & chemotherapy
IS - 12
ER -
